文献速递消化系统肿瘤

腺瘤监测与结直肠癌发病率:一项回顾性、多中心、队列研究

Adenoma surveillance and colorectal cancer incidence: a retrospective, multicentre, cohort study.
PubMed 文献 · Lancet Oncol · 2017-04-28

该回顾性多中心队列研究纳入英国17家医院1990至2010年间基线结肠镜和息肉切除后诊断为中风险腺瘤的11944例患者,随访至2014年12月31日。中位随访7.9年,210例诊断为结直肠癌;与未监测相比,1次或2次监测访视与结直肠癌发病率显著降低相关。基线结肠镜质量欠佳、近端息肉或高级别/大腺瘤(≥20 mm)者未监测时发病率高于一般人群,无这些特征者则低于一般人群。

要点

  • 中风险腺瘤患者中,1次或2次监测访视与结直肠癌发病率显著降低相关。
  • 基线结肠镜质量欠佳、近端息肉或高级别/大腺瘤(≥20 mm)者未监测时结直肠癌发病率高于一般人群。
  • 无上述特征者未监测时结直肠癌发病率低于一般人群,监测价值不明确。

核心结论

  • 结肠镜监测使大多数中风险腺瘤患者获益。
  • 部分患者基线结肠镜后已处于低风险,监测对其价值不明确。

研究设计与样本

  • 回顾性、多中心、队列研究,使用英国17家医院常规下消化道内镜和病理数据。
  • 纳入基线结肠镜和息肉切除后诊断为中风险腺瘤的患者,绝大多数(>99%)诊断于1990年1月1日至2010年12月31日。
  • 这些患者目前接受间隔3年的监测结肠镜。
  • 随访至2014年12月31日。
  • 采用Cox回归评估监测对结直肠癌发病率的影响,校正患者、操作和息肉特征。

主要发现

  • 共识别253 798例接受结肠内镜的患者,其中11 944例中风险腺瘤患者纳入分析。
  • 中位随访7.9年(IQR 5.6-11.1),诊断210例结直肠癌。
  • 5019例(42%)患者未参加监测,6925例(58%)参加一次或以上监测访视。
  • 与未监测相比,一次监测访视与结直肠癌发病率显著降低相关(校正HR 0.57,95%CI 0.40-0.80)。
  • 与未监测相比,两次监测访视与结直肠癌发病率显著降低相关(校正HR 0.51,95%CI 0.31-0.84)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Removal of adenomas reduces colorectal cancer incidence and mortality; however, the benefit of surveillance colonoscopy on colorectal cancer risk remains unclear. We examined heterogeneity in colorectal cancer incidence in intermediate-risk patients and the effect of surveillance on colorectal cancer incidence. METHODS: We did this retrospective, multicentre, cohort study using routine lower gastrointestinal endoscopy and pathology data from patients who, after baseline colonoscopy and polypectomy, were diagnosed with intermediate-risk adenomas mostly (>99%) between Jan 1, 1990, and Dec 31, 2010, at 17 hospitals in the UK. These patients are currently offered surveillance colonoscopy at intervals of 3 years. Patients were followed up through to Dec 31, 2014.We assessed the effect of surveillance on colorectal cancer incidence using Cox regression with adjustment for patient, procedural, and polyp characteristics. We defined lower-risk and higher-risk subgroups on the basis of polyp and procedural characteristics identified as colorectal cancer risk factors. We estimated colorectal cancer incidence and standardised incidence ratios (SIRs) using as standard the general population of England in 2007. This trial is registered, number ISRCTN15213649. FINDINGS: 253 798 patients who underwent colonic endoscopy were identified, of whom 11 944 with intermediate-risk adenomas were included in this analysis. After a median follow-up of 7·9 years (IQR 5·6-11·1), 210 colorectal cancers were diagnosed. 5019 (42%) patients did not attend surveillance and 6925 (58%) attended one or more surveillance visits. Compared to no surveillance, one or two surveillance visits were associated with a significant reduction in colorectal cancer incidence rate (adjusted hazard ratio 0·57, 95% CI 0·40-0·80 for one visit; 0·51, 0·31-0·84 for two visits). Without surveillance, colorectal cancer incidence in patients with a suboptimal quality colonoscopy, proximal polyps, or a high-grade or large adenoma (≥20 mm) at baseline (8865 [74%] patients) was significantly higher than in the general population (SIR 1·30, 95% CI 1·06-1·57). By contrast, in patients without these features, colorectal cancer incidence was lower than that of the general population (SIR 0·51, 95% CI 0·29-0·84). INTERPRETATION: Colonoscopy surveillance benefits most patients with intermediate-risk adenomas. However, some patients are already at low risk after baseline colonoscopy and the value of surveillance for them is unclear. FUNDING: National Institute for Health Research Health Technology Assessment, Cancer Research UK.

来源:Lancet Oncol,查看原文。版权归原作者所有。

引用

  1. Atkin W, Wooldrage K, Brenner A, et al. Adenoma surveillance and colorectal cancer incidence: a retrospective, multicentre, cohort study. Lancet Oncol. 2017. PMID: 28457708. doi:10.1016/S1470-2045(17)30187-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。